US$ 27.40
glp 1 weight loss medication Comparing Ozempic, Wegovy and Other GLP-1 Drugs GLP-TRIM - A Natural GLP-1
Description
The Key Risk: Euglycemic DKA One of the most serious concerns with GLP-1 use in Type 1 diabetes is euglycemic DKA a form of diabetic ketoacidosis where blood glucose may not be severely elevated

Now, both semaglutide and tirzepatide are FDA-approved both for diabetes and weight loss

Some of the imagery on Nooms site appears to be AI-generated, mixing cartoons with what look like real people

That is, 3.9% of these patients developed blindness from any cause while on GLP-1 RAs, vs 5.6% among non-users

Additionally, GLP-1 RAs should be considered in overweight or obese patients to reduce weight (class IIa, level B)
